Further views by the Erice working group on mother-to-child transmission of HIV type 1.
Dovie Akue
J P
JP
Babaki
P
P
Barré-Sinoussi
F
F
Charpak
N
N
de Thé
G
G
Ferreira Rea
M
M
Huraux
C
C
Ndiaye
B
B
Pratomo
H
H
Samuel
N M
NM
Wilfert
C
C
Zetterström
R
R
D000328:Adult; D019380:Anti-HIV Agents / Q000627:therapeutic use*; D005260:Female; D015658:HIV Infections / Q000635:transmission*; D015497:HIV-1; D006801:Humans; D007231:Infant, Newborn; D018445:Infectious Disease Transmission, Vertical / Q000517:prevention & control*; D019829:Nevirapine / Q000627:therapeutic use; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000188:drug therapy*; D015215:Zidovudine / Q000627:therapeutic use
D019380:Anti-HIV Agents; D015215:Zidovudine; D019829:Nevirapine